Article

Overexpression of ADAM10 correlates with poor prognosis and immune infiltrates in breast cance

2024-01-25

Abstract excerpt

<h4>Introduction: </h4> Breast cancer is still challenging despite advanced therapies. Disintegrin and metalloproteinase 10 (ADAM10) is best known for shedding the extracellular domain of transmembrane proteins, such as Notch, EGFR, HER2, E-cadherin, CD44, thus participating in carcinogenesis. Here, we performed a comprehensive analysis about the clinicopathological features, predictive value of ADAM10 and immune...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 539d19d7-6103-59cc-b636-eb2170e2780a
DOI: 10.21203/rs.3.rs-3884993/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Overexpression of ADAM10 correlates with poor prognosis and immune infiltrates in breast canceDOI 10.21203/rs.3.rs-3884993/v1Read

ADAM12 as a Clinical Prognostic Indicator Associated with Tumour Immune Infiltration in Lung AdenocarcinomaSemantic proximity Read

ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistanceSemantic proximity Read

The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?Semantic proximity Read

The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic AnalysisSemantic proximity Read

ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.Semantic proximity Read

A pan-cancer study of ADAM9’s immunological function and prognostic value particularly in liver cancerSemantic proximity Read

Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon AdenocarcinomaSemantic proximity Read

ADAM protein family – its role in tumorigenesis, mechanisms of chemoresistance and potential as diagnostic and prognostic factorsSemantic proximity Read

An Overview of ADAM9: Structure, Activation, and Regulation in Human DiseasesSemantic proximity Read

Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancerSemantic proximity Read

ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancersSemantic proximity Read

MMP1 acts as an independent prognostic biomarker correlated with immune infiltration in breast cancerSemantic proximity Read